Skip to main content

Table 6 Availability of recommended antidotes* stratified by hospital type (n = 18)

From: Availability of treatment resources for the management of acute toxic exposures and poisonings in emergency departments among various types of hospitals in Palestine: a cross-sectional study

Antidote list Total Private Government P-value
N = 18 (%) N = 8 (%) N = 10 (%)
Atropine sulphate 18 (100) 8 (100) 10 (100) >0.999
Calcium gluconate 18 (100) 8 (100) 10 (100) >0.999
Deferoxamine 10 (55.6) 0 (0.0) 10 (100) 0.000
Digoxin immune Fab 2 (11.1) 1 (12.5) 1 (10) >0.999
Dimercaprol 0 (0.0) 0 (0.0) 0 (0.0) >0.999
Ethanol (100%) 5 (27.8) 3 (37.5) 2 (20) 0.608
Fomepizole 0 (0.0) 0 (0.0) 0 (0.0) >0.999
Glucagon 8 (44.4) 6 (75) 2 (20) 0.054
Methylene blue 7 (38.9) 2 (25) 5 (50) 0.367
N-acetylcysteine 8 (44.4) 6 (75) 2 (20) 0.054
Naloxone 17 (94.4) 8 (100) 9 (90) >0.999
Polyvalent anti-venom 3 (16.7) 0 (0.0) 3 (30) 0.216
Pralidoxime 1 (5.6) 1 (12.5) 0 (0.0) 0.444
Pyridoxine 1 (5.6) 1 (12.5) 0 (0.0) 0.444
Sodium bicarbonate 18 (100) 8 (100) 10 (100) >0.999
Cyanide Kit 0 (0.0) 0 (0.0) 0 (0.0) >0.999
  1. * According to guidelines from Dart et al. antidotes [11].